Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality

Gregg C. Fonarow, R. Scott Wright, Frederick A. Spencer, Paul D. Fredrick, Wei Dong, Nathan Every, William J. French

Research output: Contribution to journalArticle

192 Citations (Scopus)

Abstract

We determined the effects of early statin treatment in acute myocardial infarction (AMI) on in-hospital morbidity and mortality. Experimental models of ischemia and reperfusion have shown that statins have early cardioprotective effects. However, the effect of statin use within the first 24 hours of admission on early morbidity and mortality in AMI has not been well studied. Data were collected on 300,823 patients who had AMI in the National Registry of Myocardial Infarction 4. In-hospital events were compared between patients who continued statin therapy received before the index AMI hospitalization (n = 17,118) or newly started statin therapy within the first 24 hours of hospitalization (n = 21,978) and patients who did not receive early statin treatment (n = 126,128) or whose statin therapy was discontinued (n = 9,411). New or continued treatment with a statin in the first 24 hours was associated with a decreased risk of mortality compared with no statin use (4.0% and 5.3% compared with 15.4% no statin). Discontinuation of statin treatment was associated with a slightly increased risk of mortality (16.5%). Early statin use was also associated with a lower incidence of cardiogenic shock, arrhythmias, cardiac arrest, rupture, but not recurrent myocardial infarction. Propensity analysis yielded mortality odds ratios of 0.46 for continued therapy, 0.42 for newly started therapy, and 1.25 for discontinued therapy for matched pairs versus no statin therapy (all p values <0.0001). In conclusion, the use of statin therapy within the first 24 hours of hospitalization for AMI is associated with a significantly lower rate of early complications and in-hospital mortality.

Original languageEnglish (US)
Pages (from-to)611-616
Number of pages6
JournalAmerican Journal of Cardiology
Volume96
Issue number5
DOIs
StatePublished - Sep 1 2005

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Myocardial Infarction
Morbidity
Mortality
Therapeutics
Hospitalization
Hospital Mortality
Heart Rupture
Cardiogenic Shock
Heart Arrest

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. / Fonarow, Gregg C.; Wright, R. Scott; Spencer, Frederick A.; Fredrick, Paul D.; Dong, Wei; Every, Nathan; French, William J.

In: American Journal of Cardiology, Vol. 96, No. 5, 01.09.2005, p. 611-616.

Research output: Contribution to journalArticle

Fonarow, Gregg C. ; Wright, R. Scott ; Spencer, Frederick A. ; Fredrick, Paul D. ; Dong, Wei ; Every, Nathan ; French, William J. / Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. In: American Journal of Cardiology. 2005 ; Vol. 96, No. 5. pp. 611-616.
@article{74c90c90ef114c10a0f82bc21d043f70,
title = "Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality",
abstract = "We determined the effects of early statin treatment in acute myocardial infarction (AMI) on in-hospital morbidity and mortality. Experimental models of ischemia and reperfusion have shown that statins have early cardioprotective effects. However, the effect of statin use within the first 24 hours of admission on early morbidity and mortality in AMI has not been well studied. Data were collected on 300,823 patients who had AMI in the National Registry of Myocardial Infarction 4. In-hospital events were compared between patients who continued statin therapy received before the index AMI hospitalization (n = 17,118) or newly started statin therapy within the first 24 hours of hospitalization (n = 21,978) and patients who did not receive early statin treatment (n = 126,128) or whose statin therapy was discontinued (n = 9,411). New or continued treatment with a statin in the first 24 hours was associated with a decreased risk of mortality compared with no statin use (4.0{\%} and 5.3{\%} compared with 15.4{\%} no statin). Discontinuation of statin treatment was associated with a slightly increased risk of mortality (16.5{\%}). Early statin use was also associated with a lower incidence of cardiogenic shock, arrhythmias, cardiac arrest, rupture, but not recurrent myocardial infarction. Propensity analysis yielded mortality odds ratios of 0.46 for continued therapy, 0.42 for newly started therapy, and 1.25 for discontinued therapy for matched pairs versus no statin therapy (all p values <0.0001). In conclusion, the use of statin therapy within the first 24 hours of hospitalization for AMI is associated with a significantly lower rate of early complications and in-hospital mortality.",
author = "Fonarow, {Gregg C.} and Wright, {R. Scott} and Spencer, {Frederick A.} and Fredrick, {Paul D.} and Wei Dong and Nathan Every and French, {William J.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1016/j.amjcard.2005.04.029",
language = "English (US)",
volume = "96",
pages = "611--616",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality

AU - Fonarow, Gregg C.

AU - Wright, R. Scott

AU - Spencer, Frederick A.

AU - Fredrick, Paul D.

AU - Dong, Wei

AU - Every, Nathan

AU - French, William J.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - We determined the effects of early statin treatment in acute myocardial infarction (AMI) on in-hospital morbidity and mortality. Experimental models of ischemia and reperfusion have shown that statins have early cardioprotective effects. However, the effect of statin use within the first 24 hours of admission on early morbidity and mortality in AMI has not been well studied. Data were collected on 300,823 patients who had AMI in the National Registry of Myocardial Infarction 4. In-hospital events were compared between patients who continued statin therapy received before the index AMI hospitalization (n = 17,118) or newly started statin therapy within the first 24 hours of hospitalization (n = 21,978) and patients who did not receive early statin treatment (n = 126,128) or whose statin therapy was discontinued (n = 9,411). New or continued treatment with a statin in the first 24 hours was associated with a decreased risk of mortality compared with no statin use (4.0% and 5.3% compared with 15.4% no statin). Discontinuation of statin treatment was associated with a slightly increased risk of mortality (16.5%). Early statin use was also associated with a lower incidence of cardiogenic shock, arrhythmias, cardiac arrest, rupture, but not recurrent myocardial infarction. Propensity analysis yielded mortality odds ratios of 0.46 for continued therapy, 0.42 for newly started therapy, and 1.25 for discontinued therapy for matched pairs versus no statin therapy (all p values <0.0001). In conclusion, the use of statin therapy within the first 24 hours of hospitalization for AMI is associated with a significantly lower rate of early complications and in-hospital mortality.

AB - We determined the effects of early statin treatment in acute myocardial infarction (AMI) on in-hospital morbidity and mortality. Experimental models of ischemia and reperfusion have shown that statins have early cardioprotective effects. However, the effect of statin use within the first 24 hours of admission on early morbidity and mortality in AMI has not been well studied. Data were collected on 300,823 patients who had AMI in the National Registry of Myocardial Infarction 4. In-hospital events were compared between patients who continued statin therapy received before the index AMI hospitalization (n = 17,118) or newly started statin therapy within the first 24 hours of hospitalization (n = 21,978) and patients who did not receive early statin treatment (n = 126,128) or whose statin therapy was discontinued (n = 9,411). New or continued treatment with a statin in the first 24 hours was associated with a decreased risk of mortality compared with no statin use (4.0% and 5.3% compared with 15.4% no statin). Discontinuation of statin treatment was associated with a slightly increased risk of mortality (16.5%). Early statin use was also associated with a lower incidence of cardiogenic shock, arrhythmias, cardiac arrest, rupture, but not recurrent myocardial infarction. Propensity analysis yielded mortality odds ratios of 0.46 for continued therapy, 0.42 for newly started therapy, and 1.25 for discontinued therapy for matched pairs versus no statin therapy (all p values <0.0001). In conclusion, the use of statin therapy within the first 24 hours of hospitalization for AMI is associated with a significantly lower rate of early complications and in-hospital mortality.

UR - http://www.scopus.com/inward/record.url?scp=23944497531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944497531&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.04.029

DO - 10.1016/j.amjcard.2005.04.029

M3 - Article

C2 - 16125480

AN - SCOPUS:23944497531

VL - 96

SP - 611

EP - 616

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -